IGC Pharma
IGC
#10740
Rank
โ‚น1.93 B
Marketcap
โ‚น16.58
Share price
-4.61%
Change (1 day)
-44.97%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

EPS for IGC Pharma (IGC)

EPS in 2026 (TTM): -โ‚น8.21

According to IGC Pharma's latest financial reports the company's current EPS (TTM) is -โ‚น8.48. In 2025 the company made an earnings per share (EPS) of -โ‚น8.48 an increase over its 2024 EPS that were of -โ‚น20.73.

EPS history for IGC Pharma from 2006 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น8.21-3.21%
2025-โ‚น8.48-59.09%
2024-โ‚น20.73-0%
2023-โ‚น20.73-26.67%
2022-โ‚น28.2742.86%
2021-โ‚น19.7910.53%
2020-โ‚น17.9046.15%
2019-โ‚น12.25116.67%
2018-โ‚น5.65-14.29%
2017-โ‚น6.60-58.82%
2016-โ‚น16.02-45.16%
2015-โ‚น29.21-16.22%
2014-โ‚น34.8715.62%
2013-โ‚น30.15-87.97%
2012-โ‚น250.65-80.15%
2011-โ‚น1,263219.05%
2010-โ‚น395.77740%
2009-โ‚น47.12-91.8%
2008-โ‚น574.80-654.55%
2007โ‚น103.65-178.57%
2006-โ‚น131.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sterling Infrastructure
STRL
โ‚น1,704-20,188.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
โ‚น385.40-4,644.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-โ‚น571.03 6,633.33%๐Ÿ‡บ๐Ÿ‡ธ USA